The gut microbiota as a potential determinant of response to GLP-1 receptor agonists: a narrative review - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Role of Gut Microbiota in Influencing Responses to GLP-1 Receptor Agonists: A Comprehensive Review

  • By

  • Luigi Regenburgh De La Motte

  • Francesca Carreras

  • Lorenzo Drago

  • July 6, 2026

Share

  • 1

    Interindividual variability in response to GLP-1 receptor agonists (GLP-1 RAs) poses challenges in managing obesity and type 2 diabetes.

  • 2

    GLP-1 RAs can remodel gut microbial communities and influence metabolite profiles, impacting metabolic health.

  • 3

    Human studies indicate GLP-1 RA therapy is associated with changes in microbial diversity and specific taxa enrichment.

  • 4

    Baseline microbiota composition may correlate with differential metabolic responses to GLP-1 RA therapy.

  • 5

    Robust longitudinal and interventional studies are needed to explore microbiome-informed stratification in clinical practice.

Original Source(s)

The gut microbiota as a potential determinant of response to GLP-1 receptor agonists: a narrative review

  • by Luigi Regenburgh De La Motte, Francesca Carreras, Lorenzo Drago

  • July 6, 2026

Related Content

Prolonged Sleep Restriction May Increase Body Weight

In a pooled analysis of two randomized crossover trials, reducing nightly sleep by about 1.5 hours for 6 weeks was associated with modest increases in body weight and waist circumference without measurable changes in body composition.

Application of Just-in-Time Adaptive Interventions in Dietary Health Management: Systematic Review

Do Sitting Patterns Matter?

Researchers analyzed UK Biobank data to determine whether spending sedentary time in prolonged vs interrupted bouts was associated with subsequent cancer incidence and cancer mortality.